Multiple sclerosis in Móstoles, central Spain

J Benito-León1, E Martin, L Vela

  • 1Service of Neurology, Hospital-Fundación de Alcorcón, Madrid, Spain.

Abstract

Insights

Multiple sclerosis (MS) prevalence in southern Europe is higher than previously thought. This study in Móstoles, Spain, found an MS prevalence of 43.4 per 100,000, confirming Spain as a medium to high-risk zone.

Area of Science:

  • Neurology
  • Epidemiology
  • Public Health

Background:

  • Southern Europe was historically considered a low to medium multiple sclerosis (MS) prevalence region.
  • Recent studies indicate higher MS prevalence rates in various parts of southern Europe, including Spain.
  • This study investigates MS prevalence in Móstoles, central Spain.

Purpose of the Study:

  • To determine the prevalence of multiple sclerosis (MS) in Móstoles, Spain.
  • To contribute to understanding the geographical distribution of MS in southern Europe.
  • To update epidemiological data on MS in the region.

Main Methods:

  • An intensive prevalence study was conducted in Móstoles, a municipality with 195,979 inhabitants.
  • Multiple data sources were utilized to identify cases.
  • The Poser criteria were applied for diagnosis.

Main Results:

  • A total of 85 patients (53 female, 32 male) were identified as definite or probable MS cases.
  • The overall prevalence of MS was calculated at 43.4 per 100,000 population (95% CI, 34.7 to 53.7).
  • The incidence rate over the last 5 years was 3.8 per 100,000 per year.

Conclusions:

  • The findings from Móstoles align with previous studies suggesting Spain is a medium to high-risk area for MS.
  • This study reinforces the need for updated epidemiological data on MS prevalence across southern Europe.
  • The results highlight the importance of continued research into MS risk factors and distribution.